Ondine Biomedical Inc. (LON:OBI – Get Free Report) rose 22.2% on Wednesday . The stock traded as high as GBX 11.90 ($0.15) and last traded at GBX 11 ($0.13). Approximately 818,763 shares traded hands during trading, an increase of 206% from the average daily volume of 267,427 shares. The stock had previously closed at GBX 9 ($0.11).
Ondine Biomedical Price Performance
The stock has a fifty day moving average of GBX 8.40 and a 200-day moving average of GBX 7.69. The company has a quick ratio of 8.26, a current ratio of 0.80 and a debt-to-equity ratio of 1,847.37. The stock has a market capitalization of £31.89 million, a price-to-earnings ratio of -383.33 and a beta of 0.10.
Ondine Biomedical Company Profile
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Read More
- Five stocks we like better than Ondine Biomedical
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- 3 Small Caps With Big Return Potential
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Do S&P 500 Stocks Tell Investors About the Market?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
